Tuesday, February 7, 2023
HomeMarketAstraZeneca withdraws U.S. application for COVID vaccine By Reuters

AstraZeneca withdraws U.S. application for COVID vaccine By Reuters

© Reuters. FILE PHOTO: People pose with syringe with needle in front of displayed AstraZeneca logo in this illustration taken, December 11, 2021. REUTERS/Dado Ruvic/Illustration
- Advertisement -

LONDON (Reuters) – AstraZeneca (NASDAQ:) is no longer pursuing U.S. approval of its COVID-19 vaccine, Chief Executive Pascal Soriot said in a media call on Thursday.

Demand for vaccines in the country is declining and the market is well served by the mRNA shots, he said.

Story Credit: investing.com

RELATED ARTICLES
- Advertisment -

Most Popular